From: Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study
Multivariate analysis
Variables
OR
95% CI
p value
IH plus IV polymyxin B
2.63
1.06–6.66
0.037
SOFA score
0.87
0.79–0.96
0.005
Septic shock
0.40
0.18–0.91
0.028